[1]
K. El-Reshaid and S. Al-Bader, “New regimen for treatment of irritable bowel syndrome with emphasis on Sulpride as the sole maintenance therapy”, J. Drug Delivery Ther., vol. 9, no. 5, pp. 154–157, Sep. 2019, doi: 10.22270/jddt.v9i5.3424.